Background Motor and cognitive impairments impact the everyday functioning of people with
MS (pwMS). The present randomized controlled trial (RCT) evaluated the benefits of a …

Background Current cognitive monitoring of people with multiple sclerosis (pwMS) is
sporadic, resource intensive and insensitive for detection of real-world cognitive …

Introduction Reliable measurement of disability in multiple sclerosis (MS) using a
comprehensive, patient self-reported scale, such as the World Health Organization Disability …

Cognitive impairment in multiple sclerosis (MS) affects approximately 40–70% of patients
and can have varying degrees of severity. Even mild cognitive impairment can impact on …

Objectives A 24-hour urine protein (24hUP) is a key measurement in the management of
lupus nephritis (LN); however, trajectories of 24hUP in LN is poorly defined. Methods Two …

Background Multiple sclerosis has a broad spectrum of clinical courses. Early identification
of patients at greater risk of accumulating disability is essential. Objectives Identify groups of …

Survival analysis holds a crucial role across diverse disciplines, such as economics,
engineering and healthcare. It empowers researchers to analyze both time-invariant and …

Multiple Sclerosis (MS) is the most frequent non-traumatic debilitating neurological disease.
It is usually diagnosed based on clinical observations and supporting data from auxiliary …

Neurological disorders represent a large and growing burden as populations age, both in
the United States and globally. The prevalence of noncommunicable neurological …

Mass spectrometry (MS) coupled with liquid chromatography (LC) or gas chromatography
(GC) has been proven to be a powerful platform in research and specialized clinical …